NAV NAVCO Pharmaceuticals Inc

Premier Canadian Income Fund (the "Fund") (TSX:PCU.UN) announces results of
operations for the year ended December 31, 2013. Net decrease in net assets from
operations amounted to $(0.1) million or $(0.02) per unit. Net assets were $5.5
million or $3.01 per unit, net of distributions to unitholders in the amount of
$0.4 million or $0.20 per unit.


The Fund's investment objectives are (a) to maximize total returns for
unitholders including both long-term appreciation in net asset value ("NAV") per
unit and distributions; and (b) to pay unitholders monthly tax efficient
distributions in an amount targeted to be 6.5% per annum on the NAV of the Fund.
The Fund invests in a portfolio principally consisting of common shares selected
from the Energy, Financial and Materials sectors of the S&P/TSX 60 Index. In
addition, the Fund may invest up to 20% of its net assets in equity securities
of other issuers selected from the S&P/TSX Composite Index.


The Fund employs a proprietary investment strategy, Strathbridge Selective
Overwriting ("SSO"), to enhance the income generated by the Portfolio and to
reduce volatility. In addition, the Fund may write cash covered put options in
respect of securities in which it is permitted to invest.


The Fund's investment portfolio is managed by its investment manager,
Strathbridge Asset Management Inc. Fund units are listed on Toronto Stock
Exchange under the symbol PCU.UN.




---------------------------------------------------------
Selected Financial Information: ($ Millions)             
---------------------------------------------------------
                                                         
Statement of Net Assets                             2013 
                                                -------- 
Assets                                         $     5.5 
Liabilities                                         (0.0)
                                              ---------- 
Net Assets (Unitholders' Equity)               $     5.5 
                                                         
Statement of Financial Operations                        
Revenue                                        $     0.2 
Expenses                                            (0.3)
                                              ---------- 
Net Investment Loss                            $    (0.1)
Net Loss on Investments                             (0.0)
                                              ---------- 
Net Decrease in Net Assets from Operations     $    (0.1)
---------------------------------------------------------



Aaron Ho, Vice-President, Finance

Commissions, trailing commissions, management fees and expenses all may be
associated with investment funds. Please read the prospectus before investing.
Investment funds are not guaranteed, their values change frequently and past
performance may not be repeated.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Strathbridge Asset Management Inc.
Investor Relations
416.681.3966; 1.800.725.7172
info@strathbridge.com
www.strathbridge.com

NAVCO Pharmaceuticals (TSXV:NAV)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

NAVCO Pharmaceuticals (TSXV:NAV)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025